100 Questions and Answers About Triple-Negative Breast Cancer

by Connie Henke Yarbro

Other authorsCynthia Cantril (Author)
Ebook, 2021

Status

Available

Call number

Online - see item details for access

Publication

Jones & Bartlett Learning LLC : Jones & Bartlett Learning

ISBN

1284181375 / 9781284181371

Description

According to the American Cancer Society, 10-15% of all breast cancer patients are diagnosed with triple-negative breast cancer (TNBC). No one with TNBC needs to be alone in their fight against this fast-growing cancer. That's where this book and the information within can help. 100 Questions & Answers About Triple-Negative Breast Cancer offers authoritative and practical answers to the most common questions asked by patients and their loved ones. What is triple-negative breast cancer? How is different than other breast cancers? What are the signs and symptoms of triple-negative breast cancer? What is targeted therapy and is it effective treatment for TNBC?Along with the answers to these and other questions, this book provides information on risk factors and prevention, diagnosis, treatment, survivorship, and more. 100 Questions & Answers About Triple-Negative Breast Cancer, Second Edition is an invaluable resource for anyone copying with the physical and emotional turmoil of this challenging type of breast cancer.… (more)

Local notes

CLICK HERE TO VIEW EBOOK: (note - this item is fully available for a limited time. If you lose access or cannot access this title, please contact a librarian - [email protected])
https://www.r2library.com/Resource/Title/1284181375

CONTENTS:
Part one: The basics of breast cancer, specifically triple-negative breast cancer
Part two: Risk factors and prevention
Part three: Inherited breast cancer
Part four: Diagnosis
Part five: Treatment for early-stage triple-negative breast cancer
Part six: Survivorship: Life after a diagnosis of triple-negative breast cancer
Part seven: Behavior and recurrence patterns of triple-negative breast cancer
Part eight: Management of advanced triple-negative breast cancer
Part nine: Clinical trials
Part ten: Crossroads: Making plans and end of life
Page: 0.063 seconds